Synthivan Tablet is an antiretroviral medication which is used to treat and prevent HIV/AIDS. It is usually recommended to use with other antiretroviral. It may also be used for prevention after a needlestick injury or other potential exposure. It is directed to be taken via the mouth once a day. Synthivan Tablet binds itself to the active site of HIV protease and prevents it from splitting the pro-form of viral proteins into the working machinery of the virus. If the HIV protease enzyme does not work then the virus is not infectious, and no mature virions are made.
Common side effects include yellowish skin, headache, abdominal pain, nausea, trouble sleeping, and fever. Severe side effects include rashes such as erythema multiform and high blood sugar. SynthivanTablet appears to be safe to use during pregnancy. It is of the protease inhibitor (PI) class and works by blocking HIV protease. SynthivanTablet should not be taken by those with hypersensitivity. Synthivan Tablet should not be taken with other medications such as triazolam, lurasidone, alfuzosin, irinotecan, rifampin, pimozide, orally administered lovastatin, midazolam, cisapride, ergot derivatives. Information given here is based on the salt and content of the medicine. Effect and uses of medicine may vary from person to person. It is advicable to consult a HIV Specialist before using this medicine.
Drug = Atazanavir + Ritonavir
Strength = 300 Mg + 100 Mg
Manufacturer = Cipla Ltd
How To Take
Take Synthivan medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. SynthivanTablet is to be taken with food.
Feeling of warmth or heat
Redness of the skin especially on the face and neck
Acid or sour stomach
Change in sense of taste
Sleepiness or unusual drowsiness
Mood or mental changes
Tender, swollen glands in the neck
Nausea and Vomiting
Pregnancy:Synthivan Tablet is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
Breast-feeding :Synthivan Tablet is recommended for use in breastfeeding women only in life-threatening conditions. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue the drug or to discontinue breastfeeding based on your clinical condition.
Hepatotoxicity :Synthivan Tablet should be used with caution in patients with a history of liver diseases and active liver diseases due to the increased risk of hepatotoxicity. Report any unusual symptoms to the doctor on priority. Replacement with a suitable alternative may be necessary based on the clinical condition of the patient.
Bleeding disorders :Synthivan Tablet should be used with caution in patients with bleeding disorders such as Hemophilia A or Hemophilia B due to an increase in the risk of excessive bleeding. Report any unusual symptoms to the doctor on priority. Replacement with a suitable alternative may be necessary based on the clinical condition of the patient.
Fat Redistribution :Synthivan Tabletmay cause fat gain or fat loss from the body. This may result in peripheral wasting, facial wasting, breast enlargement, and Cushingoid appearance. Close monitoring of body weight and body fat distribution is necessary while receiving this medicine. Any changes in the body should be informed to the doctor on priority.
Diabetes :Synthivan Tablet medicine may alter the blood glucose levels and may also increase the risk of new-onset diabetes mellitus. Close monitoring of blood glucose levels is necessary while receiving this medicine. Appropriate dose adjustments of the anti-diabetic agents or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.
Synthivan Tablet medicine is used in the treatment of human immunodeficiency virus (HIV) infection.
|Strength||300 Mg and 100 Mg|
|Generic Name||Tadalafil and Depoxetine|